PUBLISHER: Grand View Research | PRODUCT CODE: 2017806
PUBLISHER: Grand View Research | PRODUCT CODE: 2017806
The global companion animal genetics market size was estimated at USD 855.4 million in 2025 and is projected to reach USD 1,650.5 million by 2033, growing at a CAGR of 8.7% from 2026 to 2033. The companion animal genetics industry is significantly growing, driven by rising pet humanization and preventive care trends, the expansion of direct-to-consumer (DTC) models, and the rising incidence of hereditary and breed-specific disorders.
The growing prevalence of hereditary and breed-specific conditions in dogs and cats is a major driver for companion animal genetics. Popular purebred breeds often carry genetic predispositions to disorders such as hip dysplasia, cardiomyopathies, and inherited cancers. As of December 2020, the Online Mendelian Inheritance in Animals (OMIA) database documented 784 single-locus diseases or traits in dogs and 361 in cats that had been genetically explained.
Pet owners and breeders are increasingly using genetic testing to identify carriers, reduce the risk of passing on defective genes, and improve long-term health outcomes. This proactive approach not only enhances animal welfare but also reduces veterinary costs associated with treating chronic conditions. The heightened awareness of genetic disorders is fueling the adoption of companion animal genetics across global markets.
The growth of direct-to-consumer genetic testing kits has transformed access the companion animal genetics. Companies like Embark and Wisdom Panel offer easy-to-use at-home kits that provide insights into breed composition, ancestry, and health risks without requiring a veterinary visit. Rising e-commerce penetration and digital marketing have amplified consumer awareness and adoption. Subscription models and integrated wellness recommendations are further enhancing customer engagement and retention. By democratizing access to genetic information and linking it to preventive healthcare, the DTC approach significantly widens market reach and drives consistent growth within the companion animal genetics industry.
Pet owners increasingly view companion animals as family members, driving demand for personalized healthcare. This shift has boosted the adoption of genetic testing to detect hereditary conditions, predict disease risks, and ensure long-term well-being. Preventive healthcare is gaining traction, with pet parents opting for DNA tests to make informed decisions about nutrition, breeding, and lifestyle management. Moreover, increasing awareness of breed-specific disorders in dogs and cats has accelerated early adoption of genetic solutions. This trend, coupled with higher spending on veterinary services, remains a strong growth driver for the companion animal genetics industry.
In addition, the biobanks such as Mars Petcare Biobankrepresent a major step in companion animal genetics by creating a longitudinal resource of genomic, clinical, and lifestyle data. Linking genetic information to health outcomes enables early disease detection, personalized care, and preventive strategies. This unprecedented dataset offers researchers and the veterinary sector a crucial opportunity to advance precision medicine, identify new genetic markers, and drive innovation in pet healthcare.
Global Companion Animals Genetics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal genetics market report based on animal, type, distribution channel, and region.